These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2559332)

  • 1. The extent of neuronal re-uptake of 3H-noradrenaline in isolated vasa deferentia and atria of the rat.
    Schömig E; Fischer P; Schönfeld CL; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):502-8. PubMed ID: 2559332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The energy requirements for the basal efflux of 3H-noradrenaline from sympathetically innervated organs.
    Russ H; Schömig E; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):286-96. PubMed ID: 1961255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of adrenergic varicosities to the 3H-noradrenaline-releasing effect of potassium.
    Schönfeld CL; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):520-6. PubMed ID: 1811169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The steady-state concentration gradient for 3H-noradrenaline generated by uptake1 in the extracellular space of the rat vas deferens incubated with this amine.
    Schömig E; Trendelenburg U; Azevedo I; Moura D
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):41-6. PubMed ID: 1775192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choline+: a substrate of the neuronal noradrenaline carrier in the rat vas deferens.
    Ungell AL; Bönisch H; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):223-7. PubMed ID: 3027585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-dependence of the saturability of carrier-mediated noradrenaline efflux from noradrenergic neurones in the rat vas deferens.
    Bönisch H; Fuchs G; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):131-4. PubMed ID: 3703019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.
    Zeitner CJ; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):397-402. PubMed ID: 3821932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulation of outward transport of neuronal 3H-noradrenaline with the help of a two-compartment model.
    Schömig E; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):631-40. PubMed ID: 3444480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturation of monoamine oxidase by intraneuronal noradrenaline accumulation.
    Stefano FJ; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):135-41. PubMed ID: 6084816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline.
    Azevedo I; Moura D; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):245-8. PubMed ID: 2234107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of blockade of noradrenaline re-uptake on evoked tritium overflow from mouse vasa deferentia and rat cortex slices.
    el-Mas M; Hughes IE
    Br J Pharmacol; 1990 Nov; 101(3):762-8. PubMed ID: 2076491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of partial inhibition of monoamine oxidase on the steady-state rate of deamination of 3H-catecholamines in two metabolizing systems.
    Cassis L; Ludwig J; Grohmann M; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):253-61. PubMed ID: 3762740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the release of 3H-noradrenaline by dimethylphenylpiperazinium (DMPP) in the rat vas deferens.
    Niebler M; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):43-9. PubMed ID: 2314482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrodotoxin-sensitive and -resistant effects of veratridine on the noradrenergic neurone of the rat vas deferens.
    Bönisch H; Graefe KH; Keller B
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):264-70. PubMed ID: 6664380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation of the role of adrenergic innervation in the regulation of the extraneuronal uptake of [3H]-isoprenaline into rat vasa deferentia and atria.
    Morton AJ
    Br J Pharmacol; 1987 Jun; 91(2):333-46. PubMed ID: 3607361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal efflux of noradrenaline induced by tris or lithium as substitutes for extracellular sodium.
    Bönisch H; Langeloh A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):13-6. PubMed ID: 3016559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of (+/-)-dobutamine on adrenergic nerve endings.
    Fischer P; Burger A; Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):79-84. PubMed ID: 2786150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prejunctional actions of tacrine on autonomic neuroeffector transmission in rabbit isolated pulmonary artery and rat isolated atria.
    Fabiani ME; Kabo P; Story DF
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):631-43. PubMed ID: 1395107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ageing on the number of neuronal noradrenaline uptake sites in the rat vas deferens.
    Markus RP; Werneck de Avellar MC
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):405-9. PubMed ID: 1436126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy requirements for the basal efflux of noradrenaline and its metabolites from adrenergic varicosities.
    Trendelenburg U; Russ H; Schömig E
    J Neural Transm Suppl; 1991; 34():19-25. PubMed ID: 1817160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.